Seegene Inc
KOSDAQ:096530
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
20 000
34 450
|
Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Seegene Inc
Long-Term Investments
Seegene Inc
Long-Term Investments Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Long-Term Investments | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
S
|
Seegene Inc
KOSDAQ:096530
|
Long-Term Investments
â‚©59.8B
|
CAGR 3-Years
15%
|
CAGR 5-Years
73%
|
CAGR 10-Years
25%
|
|
Celltrion Inc
KRX:068270
|
Long-Term Investments
â‚©135.4B
|
CAGR 3-Years
14%
|
CAGR 5-Years
18%
|
CAGR 10-Years
28%
|
||
SK Bioscience Co Ltd
KRX:302440
|
Long-Term Investments
â‚©42.8B
|
CAGR 3-Years
693%
|
CAGR 5-Years
246%
|
CAGR 10-Years
N/A
|
||
H
|
Hugel Inc
KOSDAQ:145020
|
Long-Term Investments
â‚©23.5B
|
CAGR 3-Years
-37%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
P
|
PharmaResearch Co Ltd
KOSDAQ:214450
|
Long-Term Investments
â‚©105.8B
|
CAGR 3-Years
25%
|
CAGR 5-Years
21%
|
CAGR 10-Years
N/A
|
|
Alteogen Inc
KOSDAQ:196170
|
Long-Term Investments
â‚©2.1B
|
CAGR 3-Years
29%
|
CAGR 5-Years
41%
|
CAGR 10-Years
N/A
|
Seegene Inc
Glance View
Seegene, Inc. engages in the manufacturing and distributing of molecular diagnostics and reagents. The company is headquartered in Seoul, Seoul. The company went IPO on 2010-09-10. The firm mainly provides infectious pathogens inspection products, including allergic respiratory pathogens, sexually transmitted diseases pathogens, human papilloma virus (HPV) and other inspection products, drug resistance inspection products, single nucleotide polymorphisms (SNP) inspection products, as well as somatic mutation cancer inspection products. In addition, it is involved in the provision of automatic real-time detection instruments. The firm provides its products under the brand names of Seeplex, Anyplex and Magicplex. The firm distributes its products within domestic market and to overseas markets.
See Also
What is Seegene Inc's Long-Term Investments?
Long-Term Investments
59.8B
KRW
Based on the financial report for Sep 30, 2024, Seegene Inc's Long-Term Investments amounts to 59.8B KRW.
What is Seegene Inc's Long-Term Investments growth rate?
Long-Term Investments CAGR 10Y
25%
Over the last year, the Long-Term Investments growth was 31%. The average annual Long-Term Investments growth rates for Seegene Inc have been 15% over the past three years , 73% over the past five years , and 25% over the past ten years .